Keyphrases
Acute Rejection
31%
Adult Liver Transplantation
8%
Alcoholic Liver Disease
10%
Allograft
14%
Cause of Death
6%
Chronic Hepatitis C
11%
Cyclosporine
24%
End-stage Liver Disease
8%
FK506
30%
Graft Loss
7%
Graft Survival
19%
Hepatitis C
9%
Hepatitis C Virus
17%
Hepatitis C Virus Infection
13%
Immunosuppression
34%
Intestinal Transplantation
7%
Kidney
12%
Liver
11%
Liver Allograft
11%
Liver Graft
8%
Liver Transplant Recipients
75%
Liver Transplantation
89%
Living Donor
7%
Living Donor Liver Transplantation
15%
Longitudinal Follow-up
6%
Malignancy
23%
Mycophenolate Mofetil
16%
Mycophenolic Acid
12%
Orthotopic Liver Transplantation
13%
Patient Survival
22%
Pediatric Kidney Transplantation
7%
Pediatric Liver Transplant
10%
Pediatric Liver Transplantation
10%
Pharmacokinetics
13%
Post-liver Transplant
8%
Post-liver Transplantation
6%
Post-transplant Lymphoproliferative Disorder
15%
Prednisone
11%
Pretransplant
8%
Primary Liver Transplantation
7%
Prospective Randomized Trial
9%
Renal Function
11%
Renal Transplant Recipients
8%
Renal Transplantation
8%
Retransplantation
11%
Single Center
7%
Single-center Experience
12%
Tacrolimus
88%
Transplant Patients
6%
Transplantation
15%
Medicine and Dentistry
Acute Graft Rejection
20%
Alcohol Liver Disease
8%
Allograft
22%
Antiviral Therapy
7%
Biopsy
7%
Biopsy Technique
5%
Cancer
24%
Chronic Graft Rejection
18%
Cyclosporine
22%
End Stage Liver Disease
8%
Fibrosis
5%
Graft Failure
9%
Graft Survival
23%
Hepatitis C
19%
Hepatitis C Virus
17%
Hepatocellular Carcinoma
5%
Immunosuppressive Drug
9%
Immunosuppressive Treatment
33%
Infection
8%
Kidney Function
7%
Kidney Graft
14%
Kidney Transplantation
11%
Liver Graft
78%
Liver Transplantation
100%
Low Drug Dose
7%
Malignant Neoplasm
6%
Mycophenolic Acid
5%
Neoplasm
5%
Pediatrics
26%
Posttransplant Lymphoproliferative Disease
15%
Prednisone
5%
Recurrent Disease
17%
Retransplantation
14%
Standardized Incidence Ratio
5%
Survival Rate
13%
Tacrolimus
61%
Transplantation
20%
Virus Infection
8%
